Molecular Players in Tuberculosis Drug Development: Another Break in the Cell Wall

Author(s): Flavia Squeglia*, Maria Romano, Alessia Ruggiero, Rita Berisio.

Journal Name: Current Medicinal Chemistry

Volume 24 , Issue 36 , 2017

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer


Tuberculosis is a leading killer, especially for people living with HIV. It is a real medical need to tackle this disease, which is made difficult to treat due to the increasing spread of multi-drug-resistant and extensively drug-resistant bacterial strains. Cases of tuberculosis that are resistant to virtually all drugs currently available are increasing at an alarming rate around the world. Here, we review the current knowledge in the field of drug development against tuberculosis with a focus on the mechanisms of action of drugs and the targeted bacterial cell processes involved. Particular emphasis is dedicated to the process of cell wall synthesis, which has proven to provide strong potentialities for drug development. It is hoped that a deeper understanding of key molecular machineries to tackle will provide us with a better outline of possible antibacterial mechanisms of action and offer hints for the design of more efficient strategies to treat resistant tuberculosis in the future.

Keywords: Tuberculosis, drug, protein structure, TB drug development, cell wall, antibacterial.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Page: [3954 - 3969]
Pages: 16
DOI: 10.2174/0929867324666170208150016
Price: $65

Article Metrics

PDF: 31
PRC: 1